What was the Ukpds study?
A new analysis of UK Prospective Diabetes Study (UKPDS) data shows that a simple blood test which estimates the degree of insulin resistance at the time of diagnosis of type 2 diabetes can help to predict the development of heart failure and death many years later.
Does metformin have cardiovascular benefit?
Recent studies have also found that metformin has a positive effect on cardiovascular protection [8,9,10,11,12]. Metformin also lowers risk factors for cardiovascular disease such as blood fats [13,14,15], body weight and blood pressure.
How does Sulphonylurea work?
Sulfonylureas are widely used to treat type 2 diabetes because they stimulate insulin secretion from pancreatic beta-cells. They primarily act by binding to the SUR subunit of the ATP-sensitive potassium (K(ATP)) channel and inducing channel closure.
What is diamicron MR 60 mg used for?
DIAMICRON 60 mg MR is used to control blood glucose (sugar) in patients with Type II diabetes mellitus. This type of diabetes is also known as non-insulin-dependent diabetes (NIDDM), or maturity-onset diabetes).
Can metformin damage your heart?
Several observational and retrospective studies have shown increased mortality and worsening heart failure with the use of metformin (MET). Traditionally, heart failure (HF) was considered a contraindication to its use.
Is green tea with honey good for diabetics?
Green tea with honey may support diabetes management However, a cup of green tea with honey may be safe — or even helpful — for people with diabetes. An older analysis of 17 studies suggested that green tea may improve insulin sensitivity and lower fasting glucose and HgA1C, important blood markers for diabetes ( 23 ).
Is sulfonylurea better than metformin?
Conclusion. Sulfonylurea monotherapy is associated with higher risk for all-cause mortality, major hypoglycemic episodes, and cardiovascular events compared with metformin. Although the presence of CKD attenuated the mortality benefit, metformin may be a safer alternative to sulfonylureas in patients with CKD.
Who should not take sulfonylureas?
Sulfonylurea Precautions Sulfonylureas shouldn’t be taken by people with type 1 diabetes or diabetic ketoacidosis (a dangerous condition that can occur if high blood sugar is left untreated). People with liver or kidney problems may not be able to take sulfonylureas.
Is there an alternative to metformin?
Another type of drug, called salicylate, works in a similar way to metformin and scientists think it could be a good alternative for people with type 2 diabetes who can’t take metformin. Salicylate is already used to treat other health problems, like pain and inflammation.
Does Ginger Help diabetes?
Ginger can be an effective addition to your diabetes treatment if you use it in moderation. Eating up to 4 grams per day may help lower your blood sugar levels and regulate insulin production.
How long did The UKPDS last?
It ran for twenty years (1977 to 1997) in 23 UK clinical sites and showed conclusively that the complications of type 2 diabetes, previously often regarded as inevitable, could be reduced by improving blood glucose and/or blood pressure control. The UKPDS was designed and run by the late Professor Robert Turner and Professor Rury Holman.
Does post-trial monitoring improve risk reductions in diabetes?
The UKPDS Post-Trial monitoring results showed that the risk reductions reported in 1998 for any diabetes related endpoint and for microvascular disease were not maintained following the loss of within trial blood pressure and antihypertensive therapy differences.
What follow-up is needed for diabetic ketoacidosis (DKA)?
Long term follow up is required to determine the risk-benefit ratio of the glycaemic improvement, side effects, changes in body weight, and plasma insulin concentration. The drugs had similar glucose lowering efficacy, although most patients remained hyperglycaemic.
How effective is metformin for diabetes mellitus in obese patients?
In obese subjects metformin was as effective as the other drugs with no change in mean body weight and significant reduction in mean fasting plasma insulin concentration (-2.5 mU/l; P < 0.001). More hypoglycaemic episodes occurred with sulphonylurea or insulin than with diet or metformin.